Emmanuel Seront

13PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesPredictive and prognostic markersReaction engineering (excl. nuclear reactions)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 18, 2026
Can early 68Ga-PSMA-11 PET/CT predict 6-month disease control in patients receiving first-line systemic therapy for metastatic clear-cell renal cell carcinoma? Protocol for the multicentre prospective phase II PSMA-RENAL study in Belgium.

|Aug 13, 2026
Real-world treatment patterns and clinical outcomes in patients with non-muscle invasive bladder cancer: a nationwide evaluation.

|Apr 20, 2026
Clear Cell Renal Cell Carcinoma: Rare and Atypical Metastatic Localizations-A Case Series.

|Nov 27, 2024
Lung Toxicity Occurring During Enfortumab Vedotin Treatment: From a Priming Case Report to a Retrospective Analysis.

Grégoire Desimpel, François Zammit, Sarah Lejeune

|May 15, 2024
Targeted treatment in complex lymphatic anomaly: a case of synergistic efficacy of trametinib and sirolimus.

Emmanuel Seront, Antoine Froidure, Nicole Revencu

|Jul 19, 2023
Regression of a melanoma brain metastasis that had appeared after immune checkpoint inhibitor discontinuation: a hypothesis-generating case.

Julien Pierrard, Emmanuel Seront, Rachel Galot

Pageof 3

Frequent Collaborators

2 joint publications

Valérie Dekeuleneer

2 joint publications

Laurence M Boon

2 joint publications

Miikka Vikkula

2 joint publications

Guillaume Grisay